ETF1 antibody (AA 9-342)
Quick Overview for ETF1 antibody (AA 9-342) (ABIN7877076)
Target
See all ETF1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 9-342
-
Purpose
- eRF1 Antibody / EFT1
-
Purification
- Affinity purified
-
Immunogen
- A human recombinant partial protein (amino acids D9-K342) was used as the immunogen for the eRF1 antibody.
-
Isotype
- IgG2a
-
-
-
-
Application Notes
- Optimal dilution of the eRF1 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Buffer
- 0.5 mg/mL if reconstituted with 0.2 mL sterile DI water
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- After reconstitution, the eRF1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
-
-
- ETF1 (Eukaryotic Translation Termination Factor 1 (ETF1))
-
Alternative Name
- eRF1
-
Background
- Eukaryotic translation termination factor 1 (eRF1), also known as TB3-1, is a protein that in humans is encoded by the ETF1 gene. It is mapped to 5q31.2. This gene encodes a class-1 polypeptide chain release factor. The encoded protein plays an essential role in directing termination of mRNA translation from the termination codons UAA, UAG and UGA. This protein is a component of the SURF complex which promotes degradation of prematurely terminated mRNAs via the mechanism of nonsense-mediated mRNA decay (NMD). Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 6, 7, and X.
-
UniProt
- P62495
Target
-